Hepatitis C virus subverts pattern recognition receptors-mediated control of adaptative immunity orchestrated by dendritic cells;Comment le virus de l'hépatite C détourne la réponse immunitaire adaptative orchestrée par les cellules dendritiques

Medecine/Sciences

Volumn 26, Issue 10, 2010, Pages 869-874

  Gaël Rodrigue Gervais, Ian ^a,b   Lamarre, Daniel ^a,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Institut de Recherche en Immunologie et en Cancé rologieMontréal   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS;

EID: 78149259299     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20102610869     Document Type: Review

References (34)

1. Dzionek A, Sohma y, Nagafune J, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 2001 ; 194:1823-34.
2. Liu yj. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005 ; 23:275-306.
3. Kato H, Sato S, ybneyama M, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005 ; 23:19-28.
4. Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009 ; 227:221-33.
5. Longman RS, Talal AH, Jacobson IM, et al. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C.J Infect Dis 2005 ; 192: 497-503.
6. Sapoznikov A, Fischer JA, Zaft T, et al. Organ-dependent in vivo priming of naive CD4, but not CD8', Tcells by plasmacytoid dendritic cells., J Exp Med 2007;204:1923-33.
7. Jung S, Unutmaz D, Wong P, et al. In vivo depletion of CD11c dendritic cells abrogates priming of CD8 Tcells by exogenous cell-associated antigens. Immunity 2002; 17: 211-20.
8. Longman RS, Talal AH, Jacobson IM, et al. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 2004 ; 103:1026-9.
9. Larsson M, Babcock E, Grakoui A, et al. Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virusj Virol 2004 ; 78: 6151-61.
10. Rodrigue-Gervais IG, Jouan L, Beaulé G, et al. PoIy(LC) and LPS innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients.y Virol 2007 ; 81: 5537-46.
11. Goutagny N, Fatmi A, De Ledinghen V, et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003;187:1951-8.
12. Tsubouchi E, Akbar SM, Horiike N, et al. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J. Gastroenterol 2004 ; 39:754-62.
13. Granelli-Piperno A, Shimeliovich I, Pack M, et al. HIV-I selectively infects a subset of nonmaturing BDCAl-positive dendritic cells in human blood. J. Immunol 2006; 176: 991-8.
14. Rollier C, Drexhage JA, Verstrepen BE, et al. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 2003 ; 38: 851-8.
15. Tsubouchi E, Akbar SM, Murakami H, et al. Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy. Clin Exp Immunol 2004 ; 137:417-23.
16. Averill L, Lee WM, Karandikar NJ. Differential dysfunction in dendritic cell subsets during chronic HCV infection. Clin Immunol 2007 ; 123:40-9.
17. Della Bella S, Crosignani A, Riva A, et al. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4' T-cell proliferation in patients with hepatitis C virus infection. Immunology 2007 ; 121:283-92.
18. Miyazaki M, Kanto T, lnoue M, et al. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-l. J Med Virol 2008 ; 80:980-8.
19. yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway Science 2003 ; 301:640-3.
20. Hoebe K, Du X, Georgel P, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003 ; 424: 743-8.
21. Kumar H, Koyama S, lshii KJ, et al. Cooperation of IPS-I- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic Tcell responses. J. Immunol 2008 ; 180:683-7.
22. Rodrigue-Gervais IG, Rigsby H, Jouan L, et al. Dendritic cell inhibition is connected to exhaustion of CD8' T cell polyfunctionality during chronic hepatitis C virus infection. J. Immunol 2010 ; 184:3134-44.
23. Li K, Foy E, Ferreon JC, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005 ; 102: 2992-7.
24. Johnson CL, Owen DM, Gale M. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J. Biol Chem 2007 ; 282:10792-803.
25. Pasare C, Medzhitov R. Toll-dependent control mechanisms of CD4 Tcell activation. Immunity 2004;21:733-41.
26. Kobayashi T, Walsh PT, Walsh MC, et al. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 2003 ; 19: 353-63.
27. yamamoto M, Sato S, Hemmi H, et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003 ; 4:1144-50.
28. Spörri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4 T cell populations lacking helper function. Mat Immunol 2005 ; 6:163-70.
29. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 ; 21:685-711.
30. Probst HC, McCoy K, Okazaki T, et al. Resting dendritic cells induce peripheral CDS' T cell tolerance through PD-1 and CTLA-4. Nat Immunol 2005 ; 6:280-6.
31. Dustin LB, Rice CM. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 2007;25:71-99.
32. Nolte MA, Leibundgut-Landmann S, Joffre O, et al. Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo. J Exp Med 2007 ; 204:1487-501.
33. Wilson NS, Behrens GM, Lundie RJ, et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 2006;7:165-72.
34. young LJ, Wilson NS, Schnorrer P, et al. Dendritic cell preactivation impairs MHC class Il presentation of vaccines and endogenous viral antigens. Proc Natl Acad Sci USA 2007 ; 104:17753-8.